An Implanted Blood Vessel Support Device for Arteriovenous Fistulas: A Randomized Controlled Trial
ConclusionsNo safety signals were detected for the VasQ external support of brachiocephalic AVFs. Higher functional patency and vein luminal diameters were achieved with the device at 3 and 6 months. VasQ may safely intervene on mechanisms associated with the disturbed hemodynamic profile in the juxta-anastomotic region.FundingFunded by Laminate Medical Technologies Ltd.Trial RegistrationRegistered at ClinicalTrials.gov with study number NCT02112669.
Source: American Journal of Kidney Diseases - Category: Urology & Nephrology Source Type: research
More News: Dialysis | Hemodialysis | Israel Health | Middle East Health | Study | UK Health | Urology & Nephrology